{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:45:17Z","timestamp":1791089117085,"version":"4.1.0"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2011,2,15]],"date-time":"2011-02-15T00:00:00Z","timestamp":1297728000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0000962","type":"journal-article","created":{"date-parts":[[2011,2,16]],"date-time":"2011-02-16T00:25:31Z","timestamp":1297815931000},"page":"e962","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":66,"title":["Identification of Small Molecule Lead Compounds for Visceral Leishmaniasis Using a Novel Ex Vivo Splenic Explant Model System"],"prefix":"10.1371","volume":"5","author":[{"given":"Yaneth","family":"Osorio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno L.","family":"Travi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam R.","family":"Renslo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex G.","family":"Peniche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Melby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,2,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis.","volume":"19","author":"SL Croft","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/978-0-387-77570-8_5","article-title":"Fishing for anti-leishmania drugs: principles and problems.","volume":"625","author":"E Handman","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1128\/AAC.43.2.278","article-title":"Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes.","volume":"43","author":"M Ephros","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.exppara.2006.02.015","article-title":"Leishmania donovani: effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Indian clinical isolates to sodium stibogluconate.","volume":"114","author":"R Valiathan","year":"2006","journal-title":"Exp Parasitol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/infdis\/163.3.622","article-title":"Response to chemotherapy in experimental visceral leishmaniasis: T cell- dependent but interferon-gamma- and interleukin-2-independent.","volume":"163","author":"HW Murray","year":"1991","journal-title":"J Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1086\/315890","article-title":"Interleukin-12 regulates the response to chemotherapy in experimental visceral Leishmaniasis.","volume":"182","author":"HW Murray","year":"2000","journal-title":"J Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI114009","article-title":"Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis.","volume":"83","author":"HW Murray","year":"1989","journal-title":"J Clin Invest"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1002\/1521-4141(200010)30:10<2935::AID-IMMU2935>3.0.CO;2-Q","article-title":"Endogenous IL-4 is necessary for effective drug therapy against visceral leishmaniasis.","volume":"30","author":"J Alexander","year":"2000","journal-title":"Eur J Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.0105-2896.2004.00185.x","article-title":"Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice.","volume":"201","author":"D Sacks","year":"2004","journal-title":"Immunol Rev"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1128\/IAI.57.10.3091-3096.1989","article-title":"Comparison of T-cell responses in self-limiting versus progressive visceral Leishmania donovani infections in golden hamsters.","volume":"57","author":"C Gifawesen","year":"1989","journal-title":"Infect Immun"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.4049\/jimmunol.166.3.1912","article-title":"The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like response.","volume":"166","author":"PC Melby","year":"2001","journal-title":"J Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1128\/IAI.66.5.2135-2142.1998","article-title":"Cloning of Syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis.","volume":"66","author":"PC Melby","year":"1998","journal-title":"Infect Immun"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1086\/517817","article-title":"Splenic cytokine responses in Indian kala-azar before and after treatment.","volume":"177","author":"RT Kenney","year":"1998","journal-title":"J Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI116372","article-title":"In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma [see comments].","volume":"91","author":"CL Karp","year":"1993","journal-title":"J Clin Invest"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/infdis\/165.3.513","article-title":"L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes.","volume":"165","author":"HW Murray","year":"1992","journal-title":"J Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/jlb.55.5.682","article-title":"Human monocytes\/macrophages: NO or NO?","volume":"55","author":"M Denis","year":"1994","journal-title":"J Leuk Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.4049\/jimmunol.176.9.5519","article-title":"Reduced nitric oxide synthase 2 (NOS2) promoter activity in the Syrian hamster renders the animal functionally deficient in NOS2 activity and unable to control an intracellular pathogen.","volume":"176","author":"LE Perez","year":"2006","journal-title":"J Immunol"},{"key":"ref18","first-page":"19.12.11","article-title":"Animal models for the analysis of immune responses to leishmaniasis.","author":"D Sacks","year":"1998"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0166-6851(00)00270-X","article-title":"Episomal and stable expression of the luciferase reporter gene for quantifying Leishmania spp. infections in macrophages and in animal models.","volume":"110","author":"G Roy","year":"2000","journal-title":"Mol Biochem Parasitol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0022-1759(94)90027-2","article-title":"Determination of arginase activity in macrophages: a micromethod.","volume":"174","author":"IM Corraliza","year":"1994","journal-title":"J Immunol Methods"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1128\/IAI.66.1.18-27.1998","article-title":"Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani.","volume":"66","author":"PC Melby","year":"1998","journal-title":"Infect Immun"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1128\/IAI.63.12.4818-4825.1995","article-title":"Involvement of CD4+ T lymphocytes in induction of severe destructive Lyme arthritis in inbred LSH hamsters.","volume":"63","author":"LC Lim","year":"1995","journal-title":"Infect Immun"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1128\/IAI.58.6.1685-1690.1990","article-title":"Immune T cells sorted by flow cytometry confer protection against infection with Treponema pallidum subsp. pertenue in hamsters.","volume":"58","author":"H Liu","year":"1990","journal-title":"Infect Immun"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nn931","article-title":"From chemical to drug: neurodegeneration drug screening and the ethics of clinical trials.","volume":"5","author":"J Heemskerk","year":"2002","journal-title":"Nat Neurosci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/hmg\/ddh045","article-title":"A screen for drugs that protect against the cytotoxicity of polyglutamine-expanded androgen receptor.","volume":"13","author":"F Piccioni","year":"2004","journal-title":"Hum Mol Genet"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature03180","article-title":"Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression.","volume":"433","author":"JD Rothstein","year":"2005","journal-title":"Nature"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0003-2697(03)00389-0","article-title":"A high-throughput screen for identification of molecular mimics of Smac\/DIABLO utilizing a fluorescence polarization assay.","volume":"320","author":"CJ Glover","year":"2003","journal-title":"Anal Biochem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/adt.2006.4.273","article-title":"Validated high-throughput screening of drug-like small molecules for inhibitors of ErbB2 transcription.","volume":"4","author":"C Marx","year":"2006","journal-title":"Assay Drug Dev Technol"},{"key":"ref29","first-page":"4316","article-title":"Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.","volume":"62","author":"A Rapisarda","year":"2002","journal-title":"Cancer Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nbt1186","article-title":"Statistical practice in high-throughput screening data analysis.","volume":"24","author":"N Malo","year":"2006","journal-title":"Nat Biotechnol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.","volume":"4","author":"JH Zhang","year":"1999","journal-title":"J Biomol Screen"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/154065804322966315","article-title":"Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity assays.","volume":"2","author":"TL Riss","year":"2004","journal-title":"Assay Drug Dev Technol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1021\/np990281s","article-title":"Sesquiterpene alkaloids from Tripterygium hypoglaucum and Tripterygium wilfordii: a new class of potent anti-HIV agents.","volume":"63","author":"H Duan","year":"2000","journal-title":"J Nat Prod"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"908","DOI":"10.4049\/jimmunol.138.3.908","article-title":"An analysis of T cell responsiveness in Indian kala-azar.","volume":"138","author":"DL Sacks","year":"1987","journal-title":"J Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.0105-2896.2004.00188.x","article-title":"The immunopathology of experimental visceral leishmaniasis.","volume":"201","author":"PM Kaye","year":"2004","journal-title":"Immunol Rev"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1462-5822.2004.00468.x","article-title":"Bioluminescent Leishmania expressing luciferase for rapid and high throughput screening of drugs acting on amastigote-harbouring macrophages and for quantitative real-time monitoring of parasitism features in living mice.","volume":"7","author":"T Lang","year":"2005","journal-title":"Cell Microbiol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.parint.2006.09.001","article-title":"Advances and perspectives in Leishmania cell based drug-screening procedures.","volume":"56","author":"D Sereno","year":"2007","journal-title":"Parasitol Int"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1128\/AAC.41.4.818","article-title":"An axenic amastigote system for drug screening.","volume":"41","author":"HL Callahan","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1128\/AAC.41.5.972","article-title":"Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents.","volume":"41","author":"D Sereno","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/314896","article-title":"Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.","volume":"180","author":"R Lira","year":"1999","journal-title":"J Infect Dis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/138920008783331086","article-title":"Cell lines: a tool for in vitro drug metabolism studies.","volume":"9","author":"MT Donato","year":"2008","journal-title":"Curr Drug Metab"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0887-2333(00)00062-X","article-title":"In vitro long-term cytotoxicity testing of 27 MEIC chemicals on Hep G2 cells and comparison with acute human toxicity data.","volume":"15","author":"EM Scheers","year":"2001","journal-title":"Toxicol In Vitro"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.tiv.2005.01.002","article-title":"Cytotoxic effects of 110 reference compounds on HepG2 cells and for 60 compounds on HeLa, ECC-1 and CHO cells. II mechanistic assays on NAD(P)H, ATP and DNA contents.","volume":"19","author":"WG Schoonen","year":"2005","journal-title":"Toxicol In Vitro"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.tiv.2008.11.012","article-title":"Selection of cytotoxicity markers for the screening of new chemical entities in a pharmaceutical context: a preliminary study using a multiplexing approach.","volume":"23","author":"HH Gerets","year":"2009","journal-title":"Toxicol In Vitro"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/01926230590522284","article-title":"New technologies and screening strategies for hepatotoxicity: use of in vitro models.","volume":"33","author":"DM Dambach","year":"2005","journal-title":"Toxicol Pathol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/jac\/33.3.537","article-title":"The activity of 2-substituted quinoline alkaloids in BALB\/c mice infected with Leishmania donovani.","volume":"33","author":"A Fournet","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4269\/ajtmh.2001.65.685","article-title":"Phase 2 trial of WR6026, an orally administered 8-aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi.","volume":"65","author":"R Dietze","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/157489106775244073","article-title":"Anti-infective quinone derivatives of recent patents.","volume":"1","author":"J Koyama","year":"2006","journal-title":"Recent Pat Antiinfect Drug Discov"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1016\/j.vaccine.2005.05.045","article-title":"Pathogenicity and protective immunogenicity of cysteine proteinase-deficient mutants of Leishmania mexicana in non-murine models.","volume":"24","author":"NG Saravia","year":"2006","journal-title":"Vaccine"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1128\/AAC.01478-07","article-title":"Differential effects of quinoline antimalarials on endocytosis in Plasmodium falciparum.","volume":"52","author":"L Roberts","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.phymed.2003.10.006","article-title":"A review of natural products with antileishmanial activity.","volume":"12","author":"LG Rocha","year":"2005","journal-title":"Phytomedicine"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1126\/science.6505677","article-title":"Antidepressants cause lethal disruption of membrane function in the human protozoan parasite Leishmania.","volume":"226","author":"D Zilberstein","year":"1984","journal-title":"Science"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0020-7519(01)00259-4","article-title":"Life in vacuoles\u2013nutrient acquisition by Leishmania amastigotes.","volume":"31","author":"RJ Burchmore","year":"2001","journal-title":"Int J Parasitol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.parint.2007.09.006","article-title":"Monoquaternary ammonium derivatives inhibit growth of protozoan parasites.","volume":"57","author":"N Bahamontes-Rosa","year":"2008","journal-title":"Parasitol Int"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1128\/AAC.00919-06","article-title":"Inhibition of Plasmodium falciparum choline kinase by hexadecyltrimethylammonium bromide: a possible antimalarial mechanism.","volume":"51","author":"V Choubey","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1021\/jm960814j","article-title":"Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.","volume":"41","author":"C Chan","year":"1998","journal-title":"J Med Chem"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1128\/AAC.49.11.176-182.2005","article-title":"Antileishmanial activity of parthenolide, a sesquiterpene lactone isolated from Tanacetum parthenium.","volume":"49","author":"TS Tiuman","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/10611860410001712696","article-title":"Harmine: evaluation of its antileishmanial properties in various vesicular delivery systems.","volume":"12","author":"S Lala","year":"2004","journal-title":"J Drug Target"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"7339","DOI":"10.1021\/jm9004835","article-title":"Neglected tropical diseases: multi-target-directed ligands in the search for novel lead candidates against Trypanosoma and Leishmania.","volume":"52","author":"A Cavalli","year":"2009","journal-title":"J Med Chem"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0000962","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T06:59:16Z","timestamp":1685948356000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0000962"}},"subtitle":[],"editor":[{"given":"Timothy G.","family":"Geary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,2,15]]},"references-count":59,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,2,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0000962","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,15]]}}}